Ibyra Olaparib 150 Mg Tablet

150mg Tablet , Box

4.5 (154)

14,000

Ibyra Olaparib 150mg Tablet contains olaparib, a PARP inhibitor used to treat certain BRCA-mutated cancers, including advanced ovarian, fallopian tube, and primary peritoneal cancer. It works by blocking DNA repair in cancer cells, slowing their growth and promoting cell death. The medicine is usually prescribed after previous chemotherapy treatments and should be taken exactly as directed by your doctor. Regular monitoring is required during treatment to manage potential side effects and ensure the medicine is working effectively.

Description

Introduction to Ibyra Olaparib 150mg Tablet:

Ibyra Olaparib 150mg Tablet is a prescription medication belonging to a class of drugs called PARP (poly ADP-ribose polymerase) inhibitors, primarily used in the treatment of certain BRCA-mutated cancers. It is primarily used in the treatment of certain types of cancer. Ibyra 150mg (Olaparib) is available in different strengths, including the 150mg formulation.

Uses of Ibyra Olaparib 150mg Tablet:

Ibyra Olaparib 150mg Tablet is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

Side Effects of Ibyra Olaparib 150mg Tablet:

Like any medication, Ibyra 150mg (Olaparib) can cause side effects. Common side effects associated with Ibyra 150mg (Olaparib) 150mg include:

  • Fatigue
  • Anemia (low red blood cell count)
  • Decreased appetite
  • Respiratory tract infections

It is important to note that not all individuals will experience these side effects, and the severity may vary from person to person. If you are prescribed Ibyra 150mg (Olaparib), your healthcare provider will closely monitor you and provide guidance on managing any side effects that may arise.

It is crucial to consult with a healthcare professional for accurate and up-to-date information regarding the uses, dosage, and potential side effects of Ibyra 150mg (Olaparib) 150mg, as individual circumstances may vary.

Mechanism of Action – Ibyra Olaparib 150mg Tablet:

The mechanism of action of Ibyra 150mg (Olaparib) involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Ibyra 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes.

Contact Us

Info Table
Dose/Strength 150 mg
Brand Ibyra
Usage/Application Hospital
Form Tablet
Compostion Olaparib
Drug Name Olaparib
Prescription/Non prescription Non prescription
Packaging Type Bottle
Packaging Size 60 Tablet per Bottle
Vendor Info
Benefits
Reviews

Description

Introduction to Ibyra Olaparib 150mg Tablet:

Ibyra Olaparib 150mg Tablet is a prescription medication belonging to a class of drugs called PARP (poly ADP-ribose polymerase) inhibitors, primarily used in the treatment of certain BRCA-mutated cancers. It is primarily used in the treatment of certain types of cancer. Ibyra 150mg (Olaparib) is available in different strengths, including the 150mg formulation.

Uses of Ibyra Olaparib 150mg Tablet:

Ibyra Olaparib 150mg Tablet is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

Side Effects of Ibyra Olaparib 150mg Tablet:

Like any medication, Ibyra 150mg (Olaparib) can cause side effects. Common side effects associated with Ibyra 150mg (Olaparib) 150mg include:

  • Fatigue
  • Anemia (low red blood cell count)
  • Decreased appetite
  • Respiratory tract infections

It is important to note that not all individuals will experience these side effects, and the severity may vary from person to person. If you are prescribed Ibyra 150mg (Olaparib), your healthcare provider will closely monitor you and provide guidance on managing any side effects that may arise.

It is crucial to consult with a healthcare professional for accurate and up-to-date information regarding the uses, dosage, and potential side effects of Ibyra 150mg (Olaparib) 150mg, as individual circumstances may vary.

Mechanism of Action – Ibyra Olaparib 150mg Tablet:

The mechanism of action of Ibyra 150mg (Olaparib) involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Ibyra 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Ibyra Olaparib 150 Mg Tablet”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Ibyra Olaparib 150mg Tablet used for?
Ibyra Olaparib 150mg Tablet is a PARP inhibitor used to treat advanced ovarian, fallopian tube, or primary peritoneal cancer in patients with a BRCA1/BRCA2 gene mutation, typically after prior chemotherapy.
It blocks PARP enzymes that help repair damaged DNA in cancer cells, preventing repair and causing the cancer cells to die — especially effective in BRCA-mutated cancers.
Common side effects include fatigue, anemia, decreased appetite, and respiratory tract infections.
While listed as non-prescription in its packaging category, it should only be taken under the guidance and regular monitoring of a qualified oncologist due to its potency and side-effect profile.
It comes in a bottle containing 60 tablets.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products